MetLife holds 2026 shareholder meeting, governance decisions frame the stock

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 19:49.

MetLife Inc. (US59156R1086) has outlined its governance roadmap for the coming year following its annual shareholder meeting, while the NYSE-listed insurer’s shares continue to trade in the U.S. large-cap financials arena. The gathering sets the board composition, auditor and executive pay framework that underpin the stock’s long-term profile, according to recent meeting disclosures GuruFocus summary of the 2026 MetLife shareholder meeting.

What the 2026 meeting decided

On June 16, 2026, MetLife common shareholders voted on a slate of governance items, including director elections, auditor ratification and advisory approval of executive compensation, providing a structured view of investor sentiment on the insurer’s oversight arrangements GuruFocus coverage of the June 16, 2026 MetLife meeting. Eleven directors were elected, each to serve until the 2027 annual shareholder meeting, ensuring continuity across the boardroom for at least one more year.

Shareholders also ratified Deloitte & Touche LLP as MetLife’s independent auditor for fiscal year 2026, confirming the global firm’s role in reviewing the insurer’s financial statements and internal controls GuruFocus summary of MetLife’s auditor ratification. In addition, investors approved, on an advisory and non-binding basis, the compensation programs for MetLife’s Named Executive Officers as set out in the 2026 proxy statement, signaling support for the current incentive and pay mix.

Analyst views and earnings backdrop

The governance decisions come as MetLife moves through 2026 with a relatively robust earnings track record and an active analyst following on Wall Street, where the insurer trades under the ticker MET on the NYSE alongside peers such as Prudential Financial and Lincoln National. On May 6, 2026, MetLife reported first-quarter 2026 earnings per share of $2.42, beating the consensus estimate of $2.27 by $0.15, according to MarketBeat’s earnings data MarketBeat Q1 2026 MetLife earnings overview.

The same MarketBeat compilation shows analysts tracking MetLife’s earnings path, with estimates updated around the quarterly report and the stock closing at $87.50 on June 22, 2026, before small moves in extended trading hours MarketBeat MetLife price and estimates data. The combination of an earnings beat and a confirmed governance framework gives investors a clearer picture of the insurer’s operating and oversight environment as they assess valuation versus other U.S. life and health insurance names.

The business behind MetLife

MetLife generates most of its revenue and earnings from insurance and retirement products, with a core franchise in life insurance, group benefits and annuities across the United States and selected international markets. The company offers individual life policies, disability and dental coverage for employers, and retirement income solutions such as immediate and deferred annuities, positioning the group as a diversified provider of protection and savings products for households and corporates MetLife company overview.

Where the MetLife shares trade today

MetLife shares (US59156R1086) trade on the NYSE under the ticker MET, with MarketBeat data showing a closing price of $87.50 as of June 22, 2026, 15:59 Eastern Time, in U.S. dollars MarketBeat MetLife quote.

This article is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. All data are based on sources cited and may change over time; readers should consult original filings, analyst reports and professional advisers before making investment decisions.